查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1373203

荷爾蒙替代療法市場 - 2018-2028 年全球產業規模、佔有率、趨勢、競爭、機會和預測，按產品、給藥途徑、疾病類型、地區和競爭細分

Hormone Replacement Therapy Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028 Segmented By Product, By Route of Administration, By Disease Type, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 180 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

全球荷爾蒙替代療法 (HRT) 市場預計在 2024-2028 年預測期內將以高年複合成長率成長。在世界各個發展中國家的人們中常見的其他荷爾蒙失衡疾病的盛行率日益增加，預計將在預測期內為全球荷爾蒙替代療法市場帶來利潤豐厚的成長。全球老年人口的成長以及某些荷爾蒙失調（例如男性更年期、甲狀腺功能亢進、甲狀腺功能減退症以及其他與老年人相關的疾病）預計將在預測期內推動全球荷爾蒙替代療法市場的成長。此外，全球醫療保健基礎設施的改善導致荷爾蒙替代療法的創新，預計將在預測期內全球荷爾蒙替代療法市場出現令人印象深刻的成長。

市場區隔

全球荷爾蒙替代療法市場根據產品、給藥途徑、疾病類型、公司和地區進行細分。從產品來看，全球荷爾蒙替代療法市場分為雌激素和黃體素替代療法、HGH替代療法、甲狀腺激素替代療法、睪固酮替代療法和副甲狀腺激素替代療法。根據給藥途徑，全球荷爾蒙替代療法市場分為口服、腸胃外、經皮等。根據疾病類型，市場分為更年期、甲狀腺功能減退症、男性性腺功能減退症、生長激素缺乏症和副甲狀腺功能減退症。

市場參與者

拜耳公司、輝瑞公司、默克公司、Viatris Inc.、諾和諾德公司、禮來公司、羅氏公司（基因泰克）、久光製藥有限公司（ Noven Pharmaceuticals, Inc.)、ASCEND Therapeutics US, LLC。 （貝辛斯醫療保健）和艾伯維公司。

報告範圍：

在本報告中，除了以下詳細介紹的產業趨勢外，全球荷爾蒙替代療法市場還分為以下幾類。

荷爾蒙替代療法市場，分產品：

  • 雌激素和黃體酮替代療法
  • HGH 替代療法
  • 甲狀腺激素替代療法
  • 睾酮替代療法
  • 副甲狀腺素替代

荷爾蒙替代療法市場（依給藥途徑）：

  • 口服
  • 注射用
  • 經皮
  • 其他

荷爾蒙替代療法市場，依疾病類型：

  • 停經
  • 甲狀腺功能低下症
  • 男性性腺功能減退症
  • 生長激素缺乏
  • 副甲狀腺功能減退症

全球荷爾蒙替代療法市場，按地區：

  • 北美洲
  • 美國
  • 加拿大
  • 墨西哥
  • 亞太
  • 中國
  • 印度
  • 韓國
  • 澳洲
  • 日本
  • 歐洲
  • 德國
  • 法國
  • 英國
  • 西班牙
  • 義大利
  • 南美洲
  • 巴西
  • 阿根廷
  • 哥倫比亞
  • 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

競爭格局

  • 公司簡介：全球荷爾蒙替代療法市場主要公司的詳細分析

可用的客製化：

  • 根據給定的市場資料，TechSci Research 可根據公司的具體需求提供客製化服務。該報告可以使用以下自訂選項：

公司資訊

  • 其他市場參與者（最多五個）的詳細分析和概況分析。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 研究年份
    • 主要市場區隔

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要產業夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球荷爾蒙替代療法市場展望

  • 市場規模及預測
    • 按價值和數量
  • 市佔率及預測
    • 依產品（雌激素和黃體酮替代療法、HGH替代療法、甲狀腺激素替代療法、睪固酮替代療法和副甲狀腺激素替代療法）
    • 依給藥途徑（口服、腸胃外、經皮等）
    • 依疾病類型（更年期、甲狀腺功能低下、男性性腺功能減退症、生長激素缺乏症和副甲狀腺功能減退症）
    • 按地區
    • 按公司分類 (2022)
  • 產品市場地圖

第 6 章：北美荷爾蒙替代療法市場展望

  • 市場規模及預測
    • 按價值和數量
  • 市佔率及預測
    • 按產品分類
    • 依給藥途徑
    • 依疾病類型
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 墨西哥
    • 加拿大

第 7 章：歐洲荷爾蒙替代療法市場展望

  • 市場規模及預測
    • 按價值和數量
  • 市佔率及預測
    • 按產品分類
    • 依給藥途徑
    • 依疾病類型
    • 按國家/地區
  • 歐洲：國家分析
    • 法國
    • 德國
    • 英國
    • 義大利
    • 西班牙

第 8 章：亞太地區荷爾蒙替代療法市場展望

  • 市場規模及預測
    • 按價值和數量
  • 市佔率及預測
    • 按產品分類
    • 依給藥途徑
    • 依疾病類型
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 韓國
    • 日本
    • 澳洲

第 9 章：南美洲荷爾蒙替代療法市場展望

  • 市場規模及預測
    • 按價值和數量
  • 市佔率及預測
    • 按產品分類
    • 依給藥途徑
    • 依疾病類型
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲荷爾蒙替代療法市場展望

  • 市場規模及預測
    • 按價值和數量
  • 市佔率及預測
    • 按產品分類
    • 依給藥途徑
    • 依疾病類型
    • 按國家/地區
  • MEA：國家分析
    • 南非荷爾蒙替代療法
    • 沙烏地阿拉伯荷爾蒙替代療法
    • 阿拉伯聯合大公國荷爾蒙替代療法

第 11 章：市場動態

  • 促進要素
  • 挑戰

第 12 章：市場趨勢與發展

第 13 章：大環境分析

第 14 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第15章：競爭格局

  • 商業概覽
  • 公司概況
  • 產品與服務
  • 財務（上市公司）
  • 最近的發展
  • SWOT分析
    • Bayer AG
    • Pfizer Inc.
    • Merck & Co., Inc.
    • TherapeuticsMD, Inc.
    • Novo Nordisk A/S
    • AbbVie Inc.
    • F. Hoffmann-La Roche Ltd. (Genentech)
    • Hisamitsu Pharmaceutical Co., Inc. (Noven Pharmaceuticals, Inc.)
    • ASCEND Therapeutics US, LLC. (Besins Healthcare)
    • Halozyme Therapeutics, Inc.

第 16 章：策略建議

第 17 章：關於我們與免責聲明

簡介目錄
Product Code: 15746

Global hormone replacement therapy (HRT) market is expected to rise at a high CAGR during the forecast period, 2024-2028. Growing prevalence of other hormonal imbalance disorders which are common among people of various developing countries in the world are expected to register a lucrative growth to global hormone replacement therapy market in the forecast period. Growth in global geriatric population and certain hormonal disorders such as andropause, hyperthyroidism, hypothyroidism, and others which are associated with people during their elder age are expected to propel the growth of hormone replacement therapy market across the world in the forecast period. Furthermore, improvement in worldwide healthcare infrastructure which are leading to innovations in hormone replacement therapy are further expected to register an impressive growth to global hormone replacement therapy market in the forecast period.

Hormone Replacement Therapy (HRT) is a medical treatment that involves replacing the hormones that are produced in lower quantities in the body especially after treatment of certain types of cancer and menopause in women. Various types of hormone replacement therapy that are commonly performed across the world includes estrogen-only therapy, combination therapy, transdermal therapy, and bioidentical hormone therapy.

The United States of America, Canada, Australia, and several European countries such as France, Italy, and Sweden account for highest number of hormone replacement therapies performed among their population in the forecast period. Several health conditions that can be efficiently managed by hormone replacement therapy in the human body comprise of menopause symptoms, osteoporosis, hypogonadism, gender dysphoria, endometriosis, and breast cancer.

Rising Prevalence of Hormonal Imbalance Disorders

Hormonal imbalance disorders can be referred to development of certain health conditions which are caused by abnormality in the production, regulation, and function of hormones in the human body. Some of the hormonal imbalance disorders which can affect both men and women includes polycystic ovary syndrome (PCOS), thyroid disorders, adrenal disorders, pituitary gland disorders, reproductive disorders, parathyroid disorders, and others. Major risk factors which can lead to development of hormonal imbalances in a person include genetic predisposition, age, lifestyle choices, medical conditions, and environmental changes.

Among various hormonal disorders, polycystic ovary syndrome (PCOS) is one of the most prevalent hormonal disorders affecting women of reproductive age. It is estimated that PCOS affects 5-10% of women of reproductive age worldwide. South Asia, Middle East, and North Africa are some of the regions which account for highest number of PCOS cases in recent years. According to the report published by BMC on Reproductive Biology and Endocrinology in 2021, it has been observed that India stood at highest position for around 22.7% PCOS cases being diagnosed in the country, followed by 20% cases in Philippines, 15.9% cases in Australia, 13.7% cases in United Kingdom, 12.2% cases in United States of America, and so on.

Hormone Replacement Therapy involves taking synthetic hormones to replace the hormones that are not being produced adequately by the body. In case of polycystic ovary syndrome (PCOS), hormone replacement therapy is used to regulate menstrual cycles, reduce hair growth, and remove acne. Another common hormonal disorders which are prevailing people of every age group and gender worldwide are thyroid disorders such as hypothyroidism and hyperthyroidism. According to World Health Organization (WHO), around 750 million people are suffering from some form of thyroid disorder in the world. The prevalence of thyroid disorders increases with age which account for around 20% women over 60 years of age having some form of thyroid dysfunction. In some regions, such as Southeast Asia, Africa, and South America around 50% of people are diagnosed with iodine deficiency every year which leads to the development of goiter (enlarged thyroid gland) and hypothyroidism. Moreover, effective results in management of various hormonal disorders after hormone replacement therapy are expected to register an impressive growth of global hormone replacement therapy market in the forecast period.

Growth in Geriatric Population

With increase in age, people tend to develop more symptoms of various hormonal imbalance disorders in their body. Some of the most common hormonal imbalances which affect people during their elder age include menopause, hypothyroidism, andropause, adrenal insufficiency, and diabetes. Among various hormonal disorders, menopause accounts for highest number of instances across various developing countries of the world. According to Menopause Foundation of Canada, by 2025, more than 1 billion women in the world will be experiencing menopause. Various kind of symptoms which are experienced by people during menopause comprise of hot flushes, vaginal dryness, night sweats, weight gain, and others. According to the report published by Forth with Life in 2019, it has been observed that around 73% of people suffer from hot flushes during menopause followed by 63% of people suffering from drowsiness, 47% people from low concentration, 43% people from memory troubles, and so on. Moreover, growth in worldwide geriatric population and rise in certain hormonal imbalances which are associated with people during their elder age are further expected to register a lucrative growth to global hormone replacement therapy market in the forecast period. According to the report published by Population Reference Bureau (PRB) based on countries with the oldest populations in the world, it has been concluded that Japan is the foremost country in the world accounting for around 28.2% of geriatric people out of total population, followed by Italy with 22.8% of geriatric population, Greece, and Portugal with 21.8 %, and Germany with 21.4% of geriatric people out of the total population.

Development of Healthcare Infrastructure

Improvement in medical facilities provided by various hospitals and medical centers around the world is one of the significant factors which is expected to propel the growth of global hormone replacement therapy market in the forecast period. Moreover, establishment of various healthcare associations around the world along with availability of skilled healthcare professionals are allowing more people to undergo hormone replacement therapy in their individual countries which is thereby driving the growth of the market.

Market Segmentation

Global hormone replacement therapy market is segmented based on product, route of administration, disease type, company, and region. In terms of product, the global hormone replacement therapy market is categorized into estrogen and progesterone replacement therapy, HGH replacement therapy, thyroid hormone replacement therapy, testosterone replacement therapy, and parathyroid hormone replacement. Based on, route of administration, the global hormone replacement therapy market is segmented into oral, parenteral, transdermal, and others. Based on disease type, the market is segmented into menopause, hypothyroidism, male hypogonadism, growth hormone deficiency, and hypoparathyroidism.

Market Players

Bayer AG, Pfizer Inc., Merck & Co., Inc., Viatris Inc., Novo Nordisk A/S, Eli Lilly and Company, F. Hoffmann-La Roche Ltd. (Genentech), Hisamitsu Pharmaceutical Co., Inc. (Noven Pharmaceuticals, Inc.), ASCEND Therapeutics US, LLC. (Besins Healthcare), and AbbVie Inc.

Report Scope:

In this report, Global Hormone Replacement Therapy Market has been segmented into following categories, in addition to the industry trends which have also been detailed below.

Hormone Replacement Therapy Market, By Product:

  • Estrogen and Progesterone Replacement Therapy
  • HGH replacement therapy
  • Thyroid hormone replacement therapy
  • Testosterone Replacement Therapy
  • Parathyroid Hormone replacement

Hormone Replacement Therapy Market, By Route of Administration:

  • Oral
  • Parenteral
  • Transdermal
  • Others

Hormone Replacement Therapy Market, By Disease Type:

  • Menopause
  • Hypothyroidism
  • Male hypogonadism
  • Growth hormone deficiency
  • Hypoparathyroidism

Global Hormone Replacement Therapy Market, By region:

  • North America
  • United States
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • India
  • South Korea
  • Australia
  • Japan
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Italy
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in Global Hormone Replacement Therapy Market

Available Customizations:

  • With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Hormone Replacement Therapy Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value & Volume
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product (Estrogen & Progesterone Replacement Therapy, HGH replacement therapy, Thyroid hormone replacement therapy, Testosterone Replacement Therapy, and Parathyroid Hormone replacement)
    • 5.2.2. By Route of Administration (Oral, Parenteral, Transdermal, and Others)
    • 5.2.3. By Disease Type (Menopause, Hypothyroidism, Male hypogonadism, Growth hormone deficiency, and Hypoparathyroidism)
    • 5.2.4. By Region
    • 5.2.5. By Company (2022)
  • 5.3. Product Market Map

6. North America Hormone Replacement Therapy Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product
    • 6.2.2. By Route of Administration
    • 6.2.3. By Disease Type
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Hormone Replacement Therapy Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value & Volume
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product
        • 6.3.1.2.2. By Route of Administration
        • 6.3.1.2.3. By Disease Type
    • 6.3.2. Mexico Hormone Replacement Therapy Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value & Volume
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product
        • 6.3.2.2.2. By Route of Administration
        • 6.3.2.2.3. By Disease Type
    • 6.3.3. Canada Hormone Replacement Therapy Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value & Volume
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product
        • 6.3.3.2.2. By Route of Administration
        • 6.3.3.2.3. By Disease Type

7. Europe Hormone Replacement Therapy Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product
    • 7.2.2. By Route of Administration
    • 7.2.3. By Disease Type
    • 7.2.4. By Country
  • 7.3 Europe: Country Analysis
    • 7.3.1. France Hormone Replacement Therapy Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value & Volume
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product
        • 7.3.1.2.2. By Route of Administration
        • 7.3.1.2.3. By Disease Type
    • 7.3.2. Germany Hormone Replacement Therapy Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value & Volume
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product
        • 7.3.2.2.2. By Route of Administration
        • 7.3.2.2.3. By Disease Type
    • 7.3.3. United Kingdom Hormone Replacement Therapy Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value & Volume
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Product
        • 7.3.3.2.2. By Route of Administration
        • 7.3.3.2.3. By Disease Type
    • 7.3.4. Italy Hormone Replacement Therapy Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value & Volume
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product
        • 7.3.4.2.2. By Route of Administration
        • 7.3.4.2.3. By Disease Type
    • 7.3.5. Spain Hormone Replacement Therapy Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value & Volume
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product
        • 7.3.5.2.2. By Route of Administration
        • 7.3.5.2.3. By Disease Type

8. Asia-Pacific Hormone Replacement Therapy Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product
    • 8.2.2. By Route of Administration
    • 8.2.3. By Disease Type
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Hormone Replacement Therapy Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value & Volume
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product
        • 8.3.1.2.2. By Route of Administration
        • 8.3.1.2.3. By Disease Type
    • 8.3.2. India Hormone Replacement Therapy Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value & Volume
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product
        • 8.3.2.2.2. By Route of Administration
        • 8.3.2.2.3. By Disease Type
    • 8.3.3. South Korea Hormone Replacement Therapy Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value & Volume
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product
        • 8.3.3.2.2. By Route of Administration
        • 8.3.3.2.3. By Disease Type
    • 8.3.4. Japan Hormone Replacement Therapy Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value & Volume
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product
        • 8.3.4.2.2. By Route of Administration
        • 8.3.4.2.3. By Disease Type
    • 8.3.5. Australia Hormone Replacement Therapy Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value & Volume
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product
        • 8.3.5.2.2. By Route of Administration
        • 8.3.5.2.3. By Disease Type

9. South America Hormone Replacement Therapy Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product
    • 9.2.2. By Route of Administration
    • 9.2.3. By Disease Type
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Hormone Replacement Therapy Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value & Volume
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product
        • 9.3.1.2.2. By Route of Administration
        • 9.3.1.2.3. By Disease Type
    • 9.3.2. Argentina Hormone Replacement Therapy Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value & Volume
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product
        • 9.3.2.2.2. By Route of Administration
        • 9.3.2.2.3. By Disease Type
    • 9.3.3. Colombia Hormone Replacement Therapy Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value & Volume
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product
        • 9.3.3.2.2. By Route of Administration
        • 9.3.3.2.3. By Disease Type

10. Middle East and Africa Hormone Replacement Therapy Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product
    • 10.2.2. By Route of Administration
    • 10.2.3. By Disease Type
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Hormone Replacement Therapy Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value & Volume
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product
        • 10.3.1.2.2. By Route of Administration
        • 10.3.1.2.3. By Disease Type
    • 10.3.2. Saudi Arabia Hormone Replacement Therapy Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value & Volume
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product
        • 10.3.2.2.2. By Route of Administration
        • 10.3.2.2.3. By Disease Type
    • 10.3.3. UAE Hormone Replacement Therapy Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value & Volume
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product
        • 10.3.3.2.2. By Route of Administration
        • 10.3.3.2.3. By Disease Type

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. PESTLE Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Product

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Company Snapshot
  • 15.3. Products & Services
  • 15.4. Financials (In case of listed companies)
  • 15.5. Recent Developments
  • 15.6. SWOT Analysis
    • 15.6.1. Bayer AG
    • 15.6.2. Pfizer Inc.
    • 15.6.3. Merck & Co., Inc.
    • 15.6.4. TherapeuticsMD, Inc.
    • 15.6.5. Novo Nordisk A/S
    • 15.6.6. AbbVie Inc.
    • 15.6.7. F. Hoffmann-La Roche Ltd. (Genentech)
    • 15.6.8. Hisamitsu Pharmaceutical Co., Inc. (Noven Pharmaceuticals, Inc.)
    • 15.6.9. ASCEND Therapeutics US, LLC. (Besins Healthcare)
    • 15.6.10. Halozyme Therapeutics, Inc.

16. Strategic Recommendations

17. About Us & Disclaimer